Nicholas B. Hawkins Sells 5,968 Shares of Arteris, Inc. (NASDAQ:AIP) Stock

Arteris, Inc. (NASDAQ:AIP) CFO Nicholas B. Hawkins sold 5,968 shares of the business’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $8.57, for a total value of $51,145.76. Following the completion of the sale, the chief financial officer now directly owns 186,123 shares of the company’s stock, valued at $1,595,074.11. The trade was a 3.11 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Arteris Trading Up 2.6 %

NASDAQ:AIP opened at $8.41 on Thursday. Arteris, Inc. has a 12-month low of $5.76 and a 12-month high of $12.64. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.30. The stock’s 50 day simple moving average is $10.39 and its 200-day simple moving average is $8.83. The firm has a market cap of $344.37 million, a P/E ratio of -9.67 and a beta of 1.18.

Arteris (NASDAQ:AIP) last announced its quarterly earnings data on Tuesday, February 18th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.08). Arteris had a negative net margin of 58.27% and a negative return on equity of 828.71%. The firm had revenue of $15.49 million during the quarter, compared to analyst estimates of $15.34 million. Equities analysts anticipate that Arteris, Inc. will post -0.73 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the stock. Northland Securities raised their target price on shares of Arteris from $14.00 to $16.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 19th. Rosenblatt Securities reissued a “buy” rating and set a $15.00 price objective on shares of Arteris in a research report on Tuesday, February 18th.

Institutional Investors Weigh In On Arteris

A number of hedge funds have recently added to or reduced their stakes in the company. PVG Asset Management Corp acquired a new position in Arteris during the 4th quarter worth approximately $151,000. PharVision Advisers LLC purchased a new stake in shares of Arteris in the fourth quarter valued at approximately $173,000. Squarepoint Ops LLC acquired a new position in Arteris during the fourth quarter worth $160,000. Two Sigma Advisers LP raised its position in Arteris by 82.9% in the fourth quarter. Two Sigma Advisers LP now owns 23,600 shares of the company’s stock worth $240,000 after acquiring an additional 10,700 shares in the last quarter. Finally, Two Sigma Investments LP lifted its holdings in Arteris by 166.0% in the fourth quarter. Two Sigma Investments LP now owns 60,533 shares of the company’s stock valued at $617,000 after acquiring an additional 37,772 shares during the period. Institutional investors and hedge funds own 64.36% of the company’s stock.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.